Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page version updated to v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.5%
    Check dated 2025-09-13T16:58:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-09-06T14:30:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has added significant details regarding a facility's name and location, along with various study statuses and completion dates, while removing some location-related terms and outdated recruitment statuses.
    Difference
    69%
    Check dated 2025-08-30T11:21:25.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:32:14.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:50:47.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:24:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.